INDICATIONS
CONTRA-INDICATIONS
DOSAGE
SIDE-EFFECTS
PREGNANCY
OVERDOSE
IDENTIFICATION
PATIENT INFORMATION
VIOKASE® TABLETS
SCHEDULING STATUS:
S1
PROPRIETARY NAME
(and dosage form):
VIOKASE® TABLETS
COMPOSITION:
Each tablet contains:
| Lipase |
6 500 N.F. |
| Protease |
32 000 N.F. |
| Amylase |
48 000 N.F. |
Each tablet digests (in vitro):
| Fat |
23 g |
| Protein |
32 g |
| Starch |
48 g |
PHARMACOLOGICAL CLASSIFICATION:
A 31 Enzymatic Preparations.
PHARMACOLOGICAL ACTION:
Each tablet contains sufficient pancreatic enzymes to digest, in vitro, 32 grams of dietary protein, 48 grams of dietary starch, and 23 grams of dietary fat. Viokase is used as a digestive aid and in the treatment of pancreatic insufficiency. Viokase contains less than 1% of fat and is not enteric coated.
INDICATIONS:
Pancreatic insufficiency associated with Cystic Fibrosis, pancreatitis, post-gastrectomy, post-cholecystectomy, post-pancreatectomy. Viokase is helpful in functional dyspepsias.
CONTRA-INDICATIONS:
None.
DOSAGE AND DIRECTIONS FOR USE:
Patients with cystic fibrosis or chronic pancreatitis:
1 to 3 tablets with meals.
For aiding digestion in patients with pancreatectomy or gastrectomy:
1 to 2 tablets taken at 2 hour intervals, or as directed by a physician.
SIDE-EFFECTS AND SPECIAL PRECAUTIONS:
None. Use with caution in patients known to be allergic to pork protein.
IDENTIFICATION:
Viokase is a white to cream biconvex uncoated tablet, mottled with brown spots. It is embossed with "CE" on the one side.
PRESENTATION;
Bottles of 100 and 500 tablets.
STORAGE INSTRUCTIONS;
Store below 25°C in well-closed container.
Protect from light and moisture.
KEEP OUT OF REACH OF CHILDREN.
APPLICATION NUMBER:
H2870 (Act 101/1965).
NAME AND BUSINESS ADDRESS OF APPLICANT:
PHARMACARE LIMITED
7 Fairclough Road
Port Elizabeth 6001
DATE OF PUBLICATION OF THIS PACKAGE INSERT:
19.1.1978.
D028
A & S PRINTERS
Updated on this site November 1999
Current: March 2005
Source: Hospital Pharmacy
SAEPI HOME PAGE
TRADE NAME INDEX
GENERIC NAME INDEX
FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2005